Image

Visual Function Screening System With Special Needs Children and Typical Preschoolers

Visual Function Screening System With Special Needs Children and Typical Preschoolers

Recruiting
70 years and younger
All
Phase N/A

Powered by AI

Overview

The early visual screening of children plays a critical role in promoting visual development, especially for those with visual impairments. Among various approaches, eye-tracking based visual assessment has emerged as a promising tool, particularly for infants, toddlers, and children with developmental disabilities who are unable to complete traditional vision tests. The object of this study is to design and investigate the effectiveness of using a deep learning based, individualized eye-tracking system to assess visual function, specifically visual acuity and visual field, in typical preschool children and infants under the age of three. This study aims to establish a reliable, noninvasive visual screening method that accommodates the diverse needs and abilities of young children.

Description

The investigators will recruit a total of 1,300 participants across four key groups to support the development and validation of an individualized visual function screening system using eye-tracking technology:

  1. 300 adults to establish a reference dataset for gaze estimation models
  2. 300 typically developing preschool children aged 3 to 5 years
  3. 400 typically developing children under the age of 3
  4. 300 children with special needs, including those with developmental disabilities and visual impairments Data collection will take place over 15 to 22 months, depending on the group.

Eligibility

Inclusion Criteria:

  • A. General Group 1. Inclusion Criteria

General adults:

  1. Aged over 18 and under 70 years
  2. Willing to undergo assessment and video recording using the "Deep Visual Tracking System"
  3. Willing to sign the informed consent form

Typically developing preschool children aged 3 to 5:

  1. Currently aged between 3 (inclusive) and 5 (inclusive) years
  2. The primary caregiver agrees to allow the child to undergo assessment and video recording using the "Deep Visual Tracking System"

Children under 3 years old:

  1. Currently under 3 years of age
  2. The primary caregiver agrees to allow the child to undergo assessment and video recording using the "Deep Visual Tracking System"
  3. Exclusion Criteria

General adults:

  1. Presence of severe corneal disease or cataract that may interfere with data collection
  2. Obvious abnormalities in eye or facial appearance, such as ptosis or facial trauma affecting facial structure

Typically developing preschool children aged 3 to 5:

  1. Children with physical or mental disabilities
  2. Children diagnosed with or suspected of having developmental delay
  3. Children with obvious abnormalities in eye or facial appearance

Children under 3 years old:

(1) Children with physical or mental disabilities (2) Children diagnosed with or suspected of having developmental delay (3) Children with obvious abnormalities in eye or facial appearance

________________________________________ B. Special Needs Group

  1. Inclusion Criteria (1) Children under the age of 12 with special needs, including physical, mental, or multiple disabilities (2) The primary caregiver agrees to allow the child to undergo assessment and video recording using the "Deep Visual Tracking System"
  2. Exclusion Criteria (1) Children with refractive errors that are diagnosed by an ophthalmologist to significantly impair vision and are unable to wear corrective glasses during assessment (2) Children who are physiologically or emotionally unstable and unable to adapt and complete at least two assessment sessions
  3. Special Needs Group
  4. Inclusion Criteria (1) Children under the age of 12 with special needs, including physical, mental, or multiple disabilities (2) The primary caregiver agrees to allow the child to undergo assessment and video recording using the "Deep Visual Tracking System"

    Exclusion Criteria:

    • A. General Group
  5. Exclusion Criteria

General adults:

  1. Presence of severe corneal disease or cataract that may interfere with data collection
  2. Obvious abnormalities in eye or facial appearance, such as ptosis or facial trauma affecting facial structure

Typically developing preschool children aged 3 to 5:

  1. Children with physical or mental disabilities
  2. Children diagnosed with or suspected of having developmental delay
  3. Children with obvious abnormalities in eye or facial appearance

Children under 3 years old:

  1. Children with physical or mental disabilities
  2. Children diagnosed with or suspected of having developmental delay
  3. Children with obvious abnormalities in eye or facial appearance
  4. Special Needs Group 2. Exclusion Criteria
  5. Children with refractive errors that are diagnosed by an ophthalmologist to significantly impair vision and are unable to wear corrective glasses during assessment
  6. Children who are physiologically or emotionally unstable and unable to adapt and complete at least two assessment sessions

Study details
    Visual Function
    Vision
    Special Needs Children

NCT07081139

National Taiwan University Hospital

15 August 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.